Few
scientific discoveries have generated as much excitement - or offered as much promise - as the creation of recombinant DNA in 1972. By "recombining" artificial DNA from multiple sources, scientists changed the face of medicine, making possible the unlimited production of human proteins and thus the potential mass production of medical, agricultural, enviromental, and industrial products. This discovery set the stage for the
biotechnology revolution, offering both opportunity and risk for visionaries willing to plunge in. Amgen - now the world's largest biotechnology company - was an enthusiastic trailblazer. The Amgen Story: 25 Years of
Visionary Science and Powerful Medicine traces the